Skip to main content

Women’s Health Diagnostics Market | High Prevalence of Infectious Diseases in Women

Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market.

The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.


Target Audience:

  • Hospitals and Clinics
  • Medical Research and Development (R&D) Companies
  • Medical Device Companies
  • Women Health Diagnostics Solutions’ Vendors
  • Medical Device Manufacturers
  • Imaging and Diagnostic Centers
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors
To know about the assumptions considered for the study, download the pdf brochure

Women’s Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) – Forecast to 2021

Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures are hindering the growth of women health diagnostics market.

Scope of the Report:

The research report categorizes the women’s health diagnostics market into the following segments and subsegments:

Global women’s health diagnostics market, by application

  • Breast Cancer Testing
    • Mammography Systems
    • Breast Cancer Tumor Marker Tests
    • Blood Chemistries and Blood Cell Count
    • Biopsies
    • Other Diagnostic Imaging Tests
  • Infectious Disease Testing
    • Urinary Tract Infection Testing
    • MRSA Testing
    • Hepatitis Testing
    • Tuberculosis Testing
    • Other Infectious Disease Testing
  • Cervical Cancer Testing
    • Pap Smear
    • HPV Testing
  • Osteoporosis Testing
    • Bone Densitometry
    • In Vitro Blood Tests
  • Sexually Transmitted Disease Testing
    • Chlamydia Trachomatis And Neisseria Gonorrhoeae (Ct/Ng) Testing
    • HIV Testing
    • Other Sexually Transmitted Diseases
  • Prenatal Genetic Screening and Carrier Testing
    • Cystic Fibrosis
    • Down Syndrome and Edward Syndrome
    • TORCH Infections
    • Other Diseases
  • Ultrasound
    • OB/GYN Imaging
    • Breast Imaging
  • Pregnancy and Fertility Testing
    • Pregnancy Testing and Ovulation Prediction Kits
    • Lab-based Testing
    • Fertility Monitors
  • Ovarian Cancer Testing
    • Ovarian Cancer Tumor Marker Tests
    • Diagnostic Imaging Tests
    • Other Tests

What are the Women’s Health Diagnostics Market Segments?

The global market has been segmented, on the basis of applications, and end users. On the basis of application, the market is segmented into various segments, namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound.

Leading market players and strategies adopted

The prominent players in this market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).

For more details, visit: https://www.marketsandmarkets.com/Market-Reports/womens-health-diagnostics-market-128928901.html

Labels:

Comments

Post a Comment

Popular posts from this blog

Healthcare BPO Market To Reach $312.43 Billion By 2022 : Increasing Consolidation In The Healthcare Industry

  What This Report Will Provide? In the current market scenario, there is a growing demand for healthcare BPO services. The objective of this report is to define, describe, and forecast the market on the basis of outsourcing services including payer, provider, and pharmaceutical services and region. It provides detailed information regarding the major factors influencing the growth of healthcare outsourcing market. This report also tracks and analyzes competitive developments of the key players in terms of market developments, product portfolios, and financials. Expected Revenue Growth: Healthcare BPO market  is estimated to grow at a CAGR of 10.2% from 2017 to 2022 to reach $312.43 billion by 2022 from $191.68 billion in 2017. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022. Major Growth Boosters: Patent cliffs, complex clinical trial protocols, and new reporting requirements are forcing pha...
Post a Comment
Read more

Autoinjectors Market | Newest Industry Data, Future Trends and Forecast 2023

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs. The  global autoinjectors market  is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023). In terms of Therapy, the global autoinjectors market can be segmented into: Rheumatoid Arthritis Multiple Sclerosis Diabetes Anaphylaxis Other Therapies (Cardiovascular Diseases, Migraines, Psoriasis, and Anemia) By therapy, the rheumatoid arthritis segment is expected to account for the largest share of the market in 2018 On the basis of therapy, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therap...
Post a Comment
Read more

Inspection Machines Market To Reach USD 871 Million By 2025 - Growing Demand For Personalized Medicine

  What This Report Will Provide? This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies. Expected Revenue Growth: The  Inspection machines market  is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4% during the forecast period. Major Growth Boosters: The growth of this market is majorly driven as companies are now increasingly adopting inspection systems throughout their production lines due to the growing concerns to the regulatory mandates introduced by the government and regulatory bodies in the healthcare industry to maintain compliance with Good Manufacturing Practices ( GMP ). Download PDF Brochure:    https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085   CO...
Post a Comment
Read more